Platelet Factor 4 Attenuates Experimental Acute Liver Injury in Mice
Open Access
- 26 March 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 10, 326
Abstract
Platelet factor 4 (PF4) is a pleiotropic inflammatory chemokine, which has been implicated in various inflammatory disorders including liver fibrosis. However, its role in acute liver diseases has not yet been elucidated. Here we describe an unexpected, anti-inflammatory role of PF4. Serum concentrations of PF4 were measured in patients and mice with acute liver diseases. Acute liver injury in mice was induced either by carbon tetrachloride or by D-galactosamine hydrochloride and lipopolysaccharide. Serum levels of PF4 were decreased in patients and mice with acute liver diseases. PF4-/- mice displayed increased liver damage in both models compared to control which was associated with increased apoptosis of hepatocytes and an enhanced pro-inflammatory response of liver macrophages. In this experimental setting, PF4-/- mice were unable to generate activated Protein C (APC), a protein with anti-inflammatory activities on monocytes/macrophages. In vitro, PF4 limited the activation of liver resident macrophages. Hence, the systemic application of PF4 led to a strong amelioration of experimental liver injury. Along with reduced liver injury, PF4 improved the severity of the pro-inflammatory response of liver macrophages and induced increased levels of APC. PF4 has a yet unidentified direct anti-inflammatory effect in two models of acute liver injury. Thus, attenuation of acute liver injury by systemic administration of PF4 might offer a novel therapeutic approach for acute liver diseases.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft
- RWTH Aachen University
- Deutsche Krebshilfe
This publication has 48 references indexed in Scilit:
- Efficient Hepatic Delivery of Drugs: Novel Strategies and Their SignificanceBioMed Research International, 2013
- The chemokine receptor CXCR3 limits injury after acute toxic liver damageLaboratory Investigation, 2012
- Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HITBlood, 2011
- Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated InflammationImmunity, 2011
- Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in miceJournal of Clinical Investigation, 2010
- SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophagesNature Immunology, 2010
- The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11bJournal of Clinical Investigation, 2010
- Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein CJournal of Experimental Medicine, 2007
- Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challengeBlood, 2007
- Thrombopoietin in Acute Liver FailureHepatology, 2003